Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Cancer Institute is seeking applications through this funding opportunity to undertake a rigorous and systematic evaluation of scientific data on potential carcinogenic hazards to humans. The goal is to identify substances or exposures that may cause cancer, which is critical for directing future cancer research and supporting effective cancer control and prevention strategies. The evaluations will culminate in monographs that provide authoritative references for health policies and regulatory decisions aimed at reducing the overall cancer burden. This funding opportunity, titled the Carcinogen Hazard Assessment Monographs Program (CHAMP), explicitly excludes clinical trials and invites applicants to contribute expert analyses that will influence public health recommendations. The program is administered by the National Institutes of Health under the Department of Health and Human Services. Interested applicants can reach out to Tram Kim Lam, PhD, MPH, for further information, and the detailed announcement is available on Grants.gov. The effort represents a key step in consolidating scientific evidence to inform policy and safeguard public health.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to critically and systematically evaluate the scientific evidence on carcinogenic hazards to humans. Identifying potential carcinogens is essential for guiding and advancing cancer research, as well as informing cancer control and prevention efforts. The resulting monographs will serve as crucial references that shape health policy and regulation, ultimately helping to reduce the cancer burden for all
